2,672.40
-65.8(-2.40%)
Currency In INR
Sector
Healthcare
Industry
Drug Manufacturers - General
Employees
3211
First IPO Date
July 01, 2002
| Name | Title | Pay | Year Born |
| Mr. Bhushan Akshikar | MD & Executive Director | 66.89M | N/A |
| Mr. Juby Chandy | Whole-Time Director & Chief Financial Officer | 68.92M | 1977 |
| Mr. Ajay Avinash Nadkarni | Vice President of Administration & Real Estate and Company Secretary | 0 | N/A |
| Ms. Sharmishta Mitra | Commercial Head - Paediatric Vaccines | 0 | N/A |
| Ms. Aparajita Rajput | Vice President of Technology | 0 | N/A |
| Ms. Sukanya Choudhary | Head of Growth Emerging Market | 0 | N/A |
| Ms. Simrat Sohal | Vice President of Ethics & Compliance | 0 | N/A |
| Mr. Chinmay Sharma | Executive Vice President of Human Resources | 0 | N/A |
| Mr. Carson Dalton | Executive Vice President of Communications & Government Affairs | 0 | N/A |
| Mr. Amit G. Pandey | Executive Vice President of Legal | 0 | N/A |
GlaxoSmithKline Pharmaceuticals Limited, a healthcare company, researches, develops, manufactures, and sells pharmaceutical medicines and vaccines in India and internationally. The company offers prescription and non-prescription drugs for anti-infective, respiratory, dermatology, nutrition, gastrointestinal, and rare diseases; and consumer healthcare products. It provides its product under the Augmentin, Calpol, Ceftum, Eltroxin, CCM, Neosporin, Betnovate, T-bact, Tenovate, Flutivate, Physiogel, Zimig, Cobadex CZS, Infanrix Hexa, Synflorix, Supacef, Havrix, Menveo, Boostrix, Fluarix Tetra, Varilrix, Nucala, and Trelegy Ellipta brands. The company was formerly known as SmithKline Beecham Pharmaceuticals India Ltd. and changed its name to GlaxoSmithKline Pharmaceuticals Limited in 2001. GlaxoSmithKline Pharmaceuticals Limited was incorporated in 1924 and is headquartered in Mumbai, India.